within Pharmacolibrary.Drugs.ATC.C;

model C01BC03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.115,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Propafenone is a class 1C antiarrhythmic drug used in the treatment and prevention of supraventricular and ventricular arrhythmias. It works primarily by blocking sodium channels in the heart, reducing excitability and conduction. Propafenone is FDA-approved and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Typical adult healthy subjects, oral administration, single dose; non-poor metabolizers (extensive metabolizers)</p><h4>References</h4><ol><li><p>Ito, S, et al., &amp; Koren, G (1998). Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response. <i>Journal of clinical pharmacology</i> 38(6) 496–501. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1998.tb05786.x&quot;>10.1002/j.1552-4604.1998.tb05786.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9650538/&quot;>https://pubmed.ncbi.nlm.nih.gov/9650538</a></p></li><li><p>Zhang, H, et al., &amp; Streisand, JB (2002). Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. <i>Clinical pharmacokinetics</i> 41(9) 661–680. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200241090-00003&quot;>10.2165/00003088-200241090-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12126458/&quot;>https://pubmed.ncbi.nlm.nih.gov/12126458</a></p></li><li><p>Michaud, V, et al., &amp; Turgeon, J (2006). Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans. <i>Therapeutic drug monitoring</i> 28(6) 779–783. DOI:<a href=&quot;https://doi.org/10.1097/01.ftd.0000249945.64978.33&quot;>10.1097/01.ftd.0000249945.64978.33</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17164694/&quot;>https://pubmed.ncbi.nlm.nih.gov/17164694</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01BC03;
